We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock
GRTS

Delisted

GRTS was delisted on the 21st of October, 2024.

Back to rankings

87 hedge funds and large institutions have $85.1M invested in Gritstone bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 39 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $646K | Put options by funds: $630K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

26% less funds holding

Funds holding: 117 → 87 (-30)

48% less capital invested

Capital invested by funds: $165M → $85.1M (-$79.8M)

58% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 48

62% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 39

Holders
87
Holders Change
-30
Holders Change %
-25.64%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
15
Reduced
39
Closed
48
Calls
$646K
Puts
$630K
Net Calls
+$16K
Net Calls Change
+$597K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.87M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$2.6M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.33M
4
Millennium Management
Millennium Management
New York
+$1.28M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$5.2M
2
N
Nuveen
North Carolina
-$3.47M
3
DTC
Deep Track Capital
Connecticut
-$3.32M
4
APM
Avidity Partners Management
Texas
-$2.31M
5
State Street
State Street
Massachusetts
-$1.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
1
Redmile Group
California
$16.8M +$213K +81,022 +1%
FLSM
2
Frazier Life Sciences Management
California
$12.7M – – –
VVM
3
Versant Venture Management
California
$8.62M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.07M +$487K +185,577 +7%
PAI
5
Palo Alto Investors
California
$5.64M – – –
BlackRock
6
BlackRock
New York
$4.63M -$5.2M -1,979,522 -51%
DTC
7
Deep Track Capital
Connecticut
$4.16M -$3.32M -1,265,729 -42%
Morgan Stanley
8
Morgan Stanley
New York
$3.12M +$2.87M +1,093,446 +563%
Millennium Management
9
Millennium Management
New York
$2.64M +$1.28M +488,923 +81%
Assenagon Asset Management
10
Assenagon Asset Management
Luxembourg
$2.4M +$2.6M +991,472 New
AG
11
Artal Group
Luxembourg
$1.81M – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.47M -$677K -257,785 -30%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$1.43M +$1.19M +453,302 +325%
Citadel Advisors
14
Citadel Advisors
Florida
$1.22M -$353K -134,509 -21%
Renaissance Technologies
15
Renaissance Technologies
New York
$1.22M +$1.33M +504,873 New
CSS
16
Cubist Systematic Strategies
Connecticut
$652K +$253K +96,169 +56%
State Street
17
State Street
Massachusetts
$624K -$1.87M -712,152 -73%
E
18
Ergoteles
New York
$597K +$567K +215,800 +694%
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$579K +$180K +68,551 +40%
Wellington Management Group
20
Wellington Management Group
Massachusetts
$573K -$531 -202 -0.1%
UBS Group
21
UBS Group
Switzerland
$459K -$1.86K -710 -0.4%
Two Sigma Investments
22
Two Sigma Investments
New York
$414K +$366K +139,351 +439%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$387K -$52.5K -20,002 -11%
Goldman Sachs
24
Goldman Sachs
New York
$378K -$352K -133,882 -46%
OQS
25
Occudo Quantitative Strategies
Florida
$346K +$376K +143,137 New
1
2 3 4 5

GRTS Hedge Fund Activity: Q2 2022 in Review

87 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q2 2022, worth a combined $85.1M — down 48% from $165M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of GRTS and 20 opened new positions — a net loss of 28 holders — while 39 trimmed existing stakes and 15 added.

The largest buyer was Morgan Stanley, adding an estimated $2.87M. The largest seller was BlackRock, cutting an estimated $5.2M.

  • 87 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q2 2022, down from 117 in Q1 2022.
  • Funds reported $85.1M of Gritstone bio, Inc. Common Stock stock for Q2 2022, down 48% quarter-over-quarter.
  • 20 funds opened new Gritstone bio, Inc. Common Stock positions in Q2 2022 and 48 closed out, a net change of -28 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q2 2022 was Morgan Stanley, an estimated $2.87M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $5.2M sold.

Based on aggregated 13F filings for Q2 2022.